[News] Nicotinamide yields impressive results in skin cancer

New research suggests that oral nicotinamide (vitamin B3) reduces the incidence of new non-melanoma skin cancers (basal-cell carcinoma and squamous-cell carcinoma) and premalignant actinic keratoses in high-risk patients.

Source: The Lancet Oncology - October 30, 2015 Category: Cancer & Oncology Authors: Sanjeet Bagcchi Tags: News Source Type: research